Back to search

University of York

The Value of Pharmaceutical R&D Projects under Uncertainty and Drug Approval Policy

Abstract

dc:description.abstract

Pharmaceutical R&D projects often have the characteristics of irreversibility on investment, flexibility of investment timing, and uncertainty in cash flows. In this thesis, the real options approach is used as the evaluation tool for these projects and three continuous-time investment models are developed. In chapter 4, we discuss the effects of the investment lag and commercialization flexibility on the investment decisions under uncertainty. Chapter 5 examines which organizational structures, the decentralized or centralized pharmaceutical R&D project, are more socially desirable in terms of early investment and higher project value. Chapter 6 considers whether adding a time constraint on the drug development process will increase the investment incentives and how remuneration level will influence the quality of the products, as well as the timing of commercialization.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of York
Year dc:date.issued
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wei, Wei
Advisor dc:contributor.advisor
  • Thijssen, Jacco

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.721891

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Wei, Wei. The Value of Pharmaceutical R&D Projects under Uncertainty and Drug Approval Policy. doctoral thesis, University of York, 2016.